Prognosis factors in severe community-acquired pneumonia: A step forward

Vital Health Statistical Series (1989), National Hospital Discharge Annual Survey: 1987 Summary. National Center for Health Statistics. hyatsville, MD Series 13:99Google Scholar

Niederman MS Bass JB, Campbell D, Fein AM, Grossman RF, Mandell LA, Marie TJ, Sarosi GA, torres A, Yu VL (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418–1426PubMedGoogle Scholar

Torres A, El-Ebiary M, Zavala E, Hernandez C (1996) Severe community-acquired pneumonia. Semin Respir Crit Care Med 17:265–271Google Scholar

Örtqvist A, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen M (1990) Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalisation. Eur Respir J 3:1105–1113PubMedGoogle Scholar

Woodhead MA, MacFarlane JT, Rodgers GF (1985) Aetiology and outcome of severe community-acquired pneumonia. J Infect 10:204–210PubMedGoogle Scholar

Sörensen J, Cederholm I, Carlsson C (1986) Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 18:329–335PubMedGoogle Scholar

Feldman C, Kallembcah JM, Levy H, Reinach SG, Hurwitz MD, Thorburn JR, Koornhof HJ (1989) Community-acquired pneumonia of diverse etiology: prognosis features in patients admitted to an intensive care unit and a “severity of illness”. Intensive Care Med 15:302–307PubMedGoogle Scholar

Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia: etiology, diagnosis and treatment Am Rev Respir Dis 142:369–373PubMedGoogle Scholar

Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodriguez-Roisin R (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144:312–318PubMedGoogle Scholar

Andrews BE (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med 62:195–220PubMedGoogle Scholar

Rello J, Quintana E, Ausina V, Net A, Prats G (1993) A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103: 232–235PubMedGoogle Scholar

Moine P, Vercken JB, Chevret S, Chastang G, Gajdos P and the French study group of community-acquired pneumonia in ICU (1994) Severe community-acquired pneumonia. Etiology, epidemiology and prognostic factors. Chest 105:1487–1495PubMedGoogle Scholar

Leeper K, Torres A (1995) Community-acquired pneumonia in the intensive care unit. Clin Chest Med 16:166–70Google Scholar

Fang GD, Fine MJ, Orloff J, Arisumi D Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YE, Rihs, JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Balt) 69:307–316Google Scholar

Leroy O, Santré C, Beuscart C, Guery B, Jacquier JM, Beaucaire G (1995) A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21:24–31PubMedGoogle Scholar

Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586–599PubMedGoogle Scholar

Leroy O, Georges H, Beuscart C, Guery B, Coffinier C, Vandenbussche C, Thevenin D, Beaucaire G (1996) Severe community-acquired pneumonia in the intensive care unit: prospective validation of a prognostic score. Intensive Care Med 22:1307–1314PubMedGoogle Scholar

Ewig S, Bauer E, Hasper L, Pizzulli L, Kubini R, Lüderitz B (1995) Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur Respir J 8:392–397PubMedGoogle Scholar

Pallarés R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich P, Martin R, Gudiol F, (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474–480PubMedGoogle Scholar